Literature DB >> 35006319

[Irritable bowel syndrome and functional dyspepsia : Diagnosis and treatment].

L Gottschalk1, V Andresen2, P Layer2.   

Abstract

Irritable bowel syndrome (IBS) and functional dyspepsia are chronic diseases of the digestive tract that challenge both patients and physicians due to their difficult diagnosis and limited treatment options. The international Rome IV diagnostic criteria are commonly used for research purposes. For IBS, the diagnostic criteria based on the German S3 guideline offer a less complicated alternative for everyday clinical practice. A thorough history and basic diagnostic work-up are essential for diagnosis, as reliable biomarkers are still lacking. Clinical manifestations of both disorders are variable, and it has been useful to allocate subtypes based on leading symptom clusters; these may facilitate the choice of diagnostic tests as well as symptomatic treatment approaches. Used correctly, the combination of available drug (mostly off-label) and non-drug options can help to reduce symptoms and improve quality of life.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Functional dyspepsia/classification; Irritable bowel syndrome/classification; Nutrition therapy; Rome IV criteria; Symptom-oriented therapy

Mesh:

Year:  2022        PMID: 35006319     DOI: 10.1007/s00108-021-01218-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  6 in total

1.  Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.

Authors:  A Madisch; C J Heydenreich; V Wieland; R Hufnagel; J Hotz
Journal:  Arzneimittelforschung       Date:  1999-11

2.  A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia.

Authors:  G Rich; A Shah; N Koloski; P Funk; B Stracke; S Köhler; G Holtmann
Journal:  Neurogastroenterol Motil       Date:  2017-07-10       Impact factor: 3.598

3.  Bowel Disorders.

Authors:  Fermín Mearin; Brian E Lacy; Lin Chang; William D Chey; Anthony J Lembo; Magnus Simren; Robin Spiller
Journal:  Gastroenterology       Date:  2016-02-18       Impact factor: 22.682

4.  The Intestinal Microenvironment and Functional Gastrointestinal Disorders.

Authors:  Giovanni Barbara; Christine Feinle-Bisset; Uday C Ghoshal; Eamonn M Quigley; Javier Santos; Steve Vanner; Nathalie Vergnolle; Erwin G Zoetendal
Journal:  Gastroenterology       Date:  2016-02-18       Impact factor: 22.682

Review 5.  Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date.

Authors:  Wathsala S Nanayakkara; Paula Ml Skidmore; Leigh O'Brien; Tim J Wilkinson; Richard B Gearry
Journal:  Clin Exp Gastroenterol       Date:  2016-06-17

6.  Biopsychosocial Aspects of Functional Gastrointestinal Disorders.

Authors:  Lukas Van Oudenhove; Michael D Crowell; Douglas A Drossman; Albena D Halpert; Laurie Keefer; Jeffrey M Lackner; Tasha B Murphy; Bruce D Naliboff; Rona L Levy
Journal:  Gastroenterology       Date:  2016-02-18       Impact factor: 22.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.